Human Coagulation Factor VIII Market
1 Study Coverage
1.1 Human Coagulation Factor VIII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts 2017-2028
2.2 Global Human Coagulation Factor VIII Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Coagulation Factor VIII Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Coagulation Factor VIII Sales by Region
2.4.1 Global Human Coagulation Factor VIII Sales by Region (2017-2022)
2.4.2 Global Sales Human Coagulation Factor VIII by Region (2023-2028)
2.5 Global Human Coagulation Factor VIII Revenue by Region
2.5.1 Global Human Coagulation Factor VIII Revenue by Region (2017-2022)
2.5.2 Global Human Coagulation Factor VIII Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Coagulation Factor VIII Sales by Manufacturers
3.1.1 Global Top Human Coagulation Factor VIII Manufacturers by Sales (2017-2022)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Coagulation Factor VIII in 2021
3.2 Global Human Coagulation Factor VIII Revenue by Manufacturers
3.2.1 Global Human Coagulation Factor VIII Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor VIII Revenue in 2021
3.3 Global Human Coagulation Factor VIII Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Coagulation Factor VIII Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Coagulation Factor VIII Sales by Type
4.1.1 Global Human Coagulation Factor VIII Historical Sales by Type (2017-2022)
4.1.2 Global Human Coagulation Factor VIII Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
4.2 Global Human Coagulation Factor VIII Revenue by Type
4.2.1 Global Human Coagulation Factor VIII Historical Revenue by Type (2017-2022)
4.2.2 Global Human Coagulation Factor VIII Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
4.3 Global Human Coagulation Factor VIII Price by Type
4.3.1 Global Human Coagulation Factor VIII Price by Type (2017-2022)
4.3.2 Global Human Coagulation Factor VIII Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Coagulation Factor VIII Sales by Application
5.1.1 Global Human Coagulation Factor VIII Historical Sales by Application (2017-2022)
5.1.2 Global Human Coagulation Factor VIII Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
5.2 Global Human Coagulation Factor VIII Revenue by Application
5.2.1 Global Human Coagulation Factor VIII Historical Revenue by Application (2017-2022)
5.2.2 Global Human Coagulation Factor VIII Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
5.3 Global Human Coagulation Factor VIII Price by Application
5.3.1 Global Human Coagulation Factor VIII Price by Application (2017-2022)
5.3.2 Global Human Coagulation Factor VIII Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Coagulation Factor VIII Market Size by Type
6.1.1 North America Human Coagulation Factor VIII Sales by Type (2017-2028)
6.1.2 North America Human Coagulation Factor VIII Revenue by Type (2017-2028)
6.2 North America Human Coagulation Factor VIII Market Size by Application
6.2.1 North America Human Coagulation Factor VIII Sales by Application (2017-2028)
6.2.2 North America Human Coagulation Factor VIII Revenue by Application (2017-2028)
6.3 North America Human Coagulation Factor VIII Market Size by Country
6.3.1 North America Human Coagulation Factor VIII Sales by Country (2017-2028)
6.3.2 North America Human Coagulation Factor VIII Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Coagulation Factor VIII Market Size by Type
7.1.1 Europe Human Coagulation Factor VIII Sales by Type (2017-2028)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Type (2017-2028)
7.2 Europe Human Coagulation Factor VIII Market Size by Application
7.2.1 Europe Human Coagulation Factor VIII Sales by Application (2017-2028)
7.2.2 Europe Human Coagulation Factor VIII Revenue by Application (2017-2028)
7.3 Europe Human Coagulation Factor VIII Market Size by Country
7.3.1 Europe Human Coagulation Factor VIII Sales by Country (2017-2028)
7.3.2 Europe Human Coagulation Factor VIII Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Coagulation Factor VIII Market Size by Type
8.1.1 Asia Pacific Human Coagulation Factor VIII Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Coagulation Factor VIII Revenue by Type (2017-2028)
8.2 Asia Pacific Human Coagulation Factor VIII Market Size by Application
8.2.1 Asia Pacific Human Coagulation Factor VIII Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Coagulation Factor VIII Revenue by Application (2017-2028)
8.3 Asia Pacific Human Coagulation Factor VIII Market Size by Region
8.3.1 Asia Pacific Human Coagulation Factor VIII Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Coagulation Factor VIII Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Coagulation Factor VIII Market Size by Type
9.1.1 Latin America Human Coagulation Factor VIII Sales by Type (2017-2028)
9.1.2 Latin America Human Coagulation Factor VIII Revenue by Type (2017-2028)
9.2 Latin America Human Coagulation Factor VIII Market Size by Application
9.2.1 Latin America Human Coagulation Factor VIII Sales by Application (2017-2028)
9.2.2 Latin America Human Coagulation Factor VIII Revenue by Application (2017-2028)
9.3 Latin America Human Coagulation Factor VIII Market Size by Country
9.3.1 Latin America Human Coagulation Factor VIII Sales by Country (2017-2028)
9.3.2 Latin America Human Coagulation Factor VIII Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Type
10.1.1 Middle East and Africa Human Coagulation Factor VIII Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Application
10.2.1 Middle East and Africa Human Coagulation Factor VIII Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Coagulation Factor VIII Market Size by Country
10.3.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shire (Baxter)
11.1.1 Shire (Baxter) Corporation Information
11.1.2 Shire (Baxter) Overview
11.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shire (Baxter) Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CSL Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Grifols
11.5.1 Grifols Corporation Information
11.5.2 Grifols Overview
11.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Grifols Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Grifols Recent Developments
11.6 Biogen
11.6.1 Biogen Corporation Information
11.6.2 Biogen Overview
11.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biogen Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biogen Recent Developments
11.7 Octapharma
11.7.1 Octapharma Corporation Information
11.7.2 Octapharma Overview
11.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Octapharma Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Octapharma Recent Developments
11.8 NovoNordisk
11.8.1 NovoNordisk Corporation Information
11.8.2 NovoNordisk Overview
11.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 NovoNordisk Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NovoNordisk Recent Developments
11.9 Greencross
11.9.1 Greencross Corporation Information
11.9.2 Greencross Overview
11.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Greencross Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Greencross Recent Developments
11.10 Kedrion
11.10.1 Kedrion Corporation Information
11.10.2 Kedrion Overview
11.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Kedrion Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kedrion Recent Developments
11.11 BPL
11.11.1 BPL Corporation Information
11.11.2 BPL Overview
11.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BPL Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BPL Recent Developments
11.12 Hualan Bio
11.12.1 Hualan Bio Corporation Information
11.12.2 Hualan Bio Overview
11.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hualan Bio Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hualan Bio Recent Developments
11.13 RAAS
11.13.1 RAAS Corporation Information
11.13.2 RAAS Overview
11.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 RAAS Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 RAAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Coagulation Factor VIII Industry Chain Analysis
12.2 Human Coagulation Factor VIII Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Coagulation Factor VIII Production Mode & Process
12.4 Human Coagulation Factor VIII Sales and Marketing
12.4.1 Human Coagulation Factor VIII Sales Channels
12.4.2 Human Coagulation Factor VIII Distributors
12.5 Human Coagulation Factor VIII Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Coagulation Factor VIII Industry Trends
13.2 Human Coagulation Factor VIII Market Drivers
13.3 Human Coagulation Factor VIII Market Challenges
13.4 Human Coagulation Factor VIII Market Restraints
14 Key Findings in The Global Human Coagulation Factor VIII Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Recombinant Factor VIII
Table 3. Major Manufacturers of Plasma-derived Factor VIII
Table 4. Global Human Coagulation Factor VIII Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Coagulation Factor VIII Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Coagulation Factor VIII Sales by Region (2017-2022) & (K Bottles)
Table 7. Global Human Coagulation Factor VIII Sales Market Share by Region (2017-2022)
Table 8. Global Human Coagulation Factor VIII Sales by Region (2023-2028) & (K Bottles)
Table 9. Global Human Coagulation Factor VIII Sales Market Share by Region (2023-2028)
Table 10. Global Human Coagulation Factor VIII Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Revenue Market Share by Region (2017-2022)
Table 12. Global Human Coagulation Factor VIII Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Coagulation Factor VIII Revenue Market Share by Region (2023-2028)
Table 14. Global Human Coagulation Factor VIII Sales by Manufacturers (2017-2022) & (K Bottles)
Table 15. Global Human Coagulation Factor VIII Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Coagulation Factor VIII Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2017-2022)
Table 18. Human Coagulation Factor VIII Price by Manufacturers (2017-2022) &(USD/Bottle)
Table 19. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2021)
Table 21. Human Coagulation Factor VIII Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Coagulation Factor VIII Product Offered
Table 23. Date of Manufacturers Enter into Human Coagulation Factor VIII Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 26. Global Human Coagulation Factor VIII Sales by Type (2023-2028) & (K Bottles)
Table 27. Global Human Coagulation Factor VIII Sales Share by Type (2017-2022)
Table 28. Global Human Coagulation Factor VIII Sales Share by Type (2023-2028)
Table 29. Global Human Coagulation Factor VIII Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Human Coagulation Factor VIII Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Human Coagulation Factor VIII Revenue Share by Type (2017-2022)
Table 32. Global Human Coagulation Factor VIII Revenue Share by Type (2023-2028)
Table 33. Human Coagulation Factor VIII Price by Type (2017-2022) & (USD/Bottle)
Table 34. Global Human Coagulation Factor VIII Price Forecast by Type (2023-2028) & (USD/Bottle)
Table 35. Global Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 36. Global Human Coagulation Factor VIII Sales by Application (2023-2028) & (K Bottles)
Table 37. Global Human Coagulation Factor VIII Sales Share by Application (2017-2022)
Table 38. Global Human Coagulation Factor VIII Sales Share by Application (2023-2028)
Table 39. Global Human Coagulation Factor VIII Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Coagulation Factor VIII Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Coagulation Factor VIII Revenue Share by Application (2017-2022)
Table 42. Global Human Coagulation Factor VIII Revenue Share by Application (2023-2028)
Table 43. Human Coagulation Factor VIII Price by Application (2017-2022) & (USD/Bottle)
Table 44. Global Human Coagulation Factor VIII Price Forecast by Application (2023-2028) & (USD/Bottle)
Table 45. North America Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 46. North America Human Coagulation Factor VIII Sales by Type (2023-2028) & (K Bottles)
Table 47. North America Human Coagulation Factor VIII Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Human Coagulation Factor VIII Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 50. North America Human Coagulation Factor VIII Sales by Application (2023-2028) & (K Bottles)
Table 51. North America Human Coagulation Factor VIII Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Coagulation Factor VIII Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 54. North America Human Coagulation Factor VIII Sales by Country (2023-2028) & (K Bottles)
Table 55. North America Human Coagulation Factor VIII Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Coagulation Factor VIII Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 58. Europe Human Coagulation Factor VIII Sales by Type (2023-2028) & (K Bottles)
Table 59. Europe Human Coagulation Factor VIII Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Human Coagulation Factor VIII Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 62. Europe Human Coagulation Factor VIII Sales by Application (2023-2028) & (K Bottles)
Table 63. Europe Human Coagulation Factor VIII Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Coagulation Factor VIII Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 66. Europe Human Coagulation Factor VIII Sales by Country (2023-2028) & (K Bottles)
Table 67. Europe Human Coagulation Factor VIII Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Coagulation Factor VIII Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 70. Asia Pacific Human Coagulation Factor VIII Sales by Type (2023-2028) & (K Bottles)
Table 71. Asia Pacific Human Coagulation Factor VIII Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Coagulation Factor VIII Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 74. Asia Pacific Human Coagulation Factor VIII Sales by Application (2023-2028) & (K Bottles)
Table 75. Asia Pacific Human Coagulation Factor VIII Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Coagulation Factor VIII Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Coagulation Factor VIII Sales by Region (2017-2022) & (K Bottles)
Table 78. Asia Pacific Human Coagulation Factor VIII Sales by Region (2023-2028) & (K Bottles)
Table 79. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 82. Latin America Human Coagulation Factor VIII Sales by Type (2023-2028) & (K Bottles)
Table 83. Latin America Human Coagulation Factor VIII Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Human Coagulation Factor VIII Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 86. Latin America Human Coagulation Factor VIII Sales by Application (2023-2028) & (K Bottles)
Table 87. Latin America Human Coagulation Factor VIII Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Coagulation Factor VIII Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 90. Latin America Human Coagulation Factor VIII Sales by Country (2023-2028) & (K Bottles)
Table 91. Latin America Human Coagulation Factor VIII Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Coagulation Factor VIII Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 94. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2023-2028) & (K Bottles)
Table 95. Middle East and Africa Human Coagulation Factor VIII Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Coagulation Factor VIII Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 98. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2023-2028) & (K Bottles)
Table 99. Middle East and Africa Human Coagulation Factor VIII Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Coagulation Factor VIII Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 102. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2023-2028) & (K Bottles)
Table 103. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2023-2028) & (US$ Million)
Table 105. Shire (Baxter) Corporation Information
Table 106. Shire (Baxter) Description and Major Businesses
Table 107. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 108. Shire (Baxter) Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Shire (Baxter) Recent Developments
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 113. Bayer Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Recent Developments
Table 115. CSL Corporation Information
Table 116. CSL Description and Major Businesses
Table 117. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 118. CSL Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. CSL Recent Developments
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Major Businesses
Table 122. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 123. Pfizer Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Pfizer Recent Developments
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Major Businesses
Table 127. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 128. Grifols Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Grifols Recent Developments
Table 130. Biogen Corporation Information
Table 131. Biogen Description and Major Businesses
Table 132. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 133. Biogen Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Biogen Recent Developments
Table 135. Octapharma Corporation Information
Table 136. Octapharma Description and Major Businesses
Table 137. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 138. Octapharma Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Octapharma Recent Developments
Table 140. NovoNordisk Corporation Information
Table 141. NovoNordisk Description and Major Businesses
Table 142. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 143. NovoNordisk Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. NovoNordisk Recent Developments
Table 145. Greencross Corporation Information
Table 146. Greencross Description and Major Businesses
Table 147. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 148. Greencross Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Greencross Recent Developments
Table 150. Kedrion Corporation Information
Table 151. Kedrion Description and Major Businesses
Table 152. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 153. Kedrion Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Kedrion Recent Developments
Table 155. BPL Corporation Information
Table 156. BPL Description and Major Businesses
Table 157. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 158. BPL Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. BPL Recent Developments
Table 160. Hualan Bio Corporation Information
Table 161. Hualan Bio Description and Major Businesses
Table 162. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 163. Hualan Bio Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Hualan Bio Recent Developments
Table 165. RAAS Corporation Information
Table 166. RAAS Description and Major Businesses
Table 167. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 168. RAAS Human Coagulation Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. RAAS Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Human Coagulation Factor VIII Distributors List
Table 173. Human Coagulation Factor VIII Customers List
Table 174. Human Coagulation Factor VIII Market Trends
Table 175. Human Coagulation Factor VIII Market Drivers
Table 176. Human Coagulation Factor VIII Market Challenges
Table 177. Human Coagulation Factor VIII Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 3. Global Human Coagulation Factor VIII Market Share by Type in 2021 & 2028
Figure 3. Recombinant Factor VIII Product Picture
Figure 4. Plasma-derived Factor VIII Product Picture
Figure 5. Global Human Coagulation Factor VIII Market Share by Application in 2021 & 2028
Figure 6. Hemophilia A
Figure 7. Spontanous / Trauma
Figure 8. Surgical
Figure 9. Other
Figure 10. Human Coagulation Factor VIII Report Years Considered
Figure 11. Global Human Coagulation Factor VIII Sales 2017-2028 (K Bottles)
Figure 12. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Coagulation Factor VIII Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Coagulation Factor VIII Sales Market Share by Region (2017-2022)
Figure 16. Global Human Coagulation Factor VIII Sales Market Share by Region (2023-2028)
Figure 17. North America Human Coagulation Factor VIII Sales YoY (2017-2028) & (K Bottles)
Figure 18. North America Human Coagulation Factor VIII Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Coagulation Factor VIII Sales YoY (2017-2028) & (K Bottles)
Figure 20. Europe Human Coagulation Factor VIII Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Coagulation Factor VIII Sales YoY (2017-2028) & (K Bottles)
Figure 22. Asia-Pacific Human Coagulation Factor VIII Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Human Coagulation Factor VIII Sales YoY (2017-2028) & (K Bottles)
Figure 24. Latin America Human Coagulation Factor VIII Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Human Coagulation Factor VIII Sales YoY (2017-2028) & (K Bottles)
Figure 26. Middle East & Africa Human Coagulation Factor VIII Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Human Coagulation Factor VIII Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Coagulation Factor VIII in the World: Market Share by Human Coagulation Factor VIII Revenue in 2021
Figure 29. Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
Figure 31. Global Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
Figure 33. Global Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
Figure 34. North America Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
Figure 35. North America Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
Figure 36. North America Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
Figure 37. North America Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
Figure 38. North America Human Coagulation Factor VIII Sales Share by Country (2017-2028)
Figure 39. North America Human Coagulation Factor VIII Revenue Share by Country (2017-2028)
Figure 40. U.S. Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
Figure 44. Europe Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
Figure 46. Europe Human Coagulation Factor VIII Sales Share by Country (2017-2028)
Figure 47. Europe Human Coagulation Factor VIII Revenue Share by Country (2017-2028)
Figure 48. Germany Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 49. France Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Coagulation Factor VIII Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Human Coagulation Factor VIII Revenue Share by Region (2017-2028)
Figure 59. China Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 62. India Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
Figure 70. Latin America Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
Figure 72. Latin America Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Human Coagulation Factor VIII Sales Share by Country (2017-2028)
Figure 74. Latin America Human Coagulation Factor VIII Revenue Share by Country (2017-2028)
Figure 75. Mexico Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Coagulation Factor VIII Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Human Coagulation Factor VIII Revenue Share by Country (2017-2028)
Figure 84. Turkey Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Human Coagulation Factor VIII Revenue (2017-2028) & (US$ Million)
Figure 87. Human Coagulation Factor VIII Value Chain
Figure 88. Human Coagulation Factor VIII Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
